Target intelligence / Profile preview

Endogenous antioxidant enzyme system (None)

Target
None
Molecular classification
Enzyme, Oxidoreductase
01

Overview

Endogenous antioxidant enzyme system refers to multiple enzymes produced by the body, notably superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), thioredoxin, and peroxiredoxins, among others[1][2]. These enzymes detoxify reactive oxygen species (ROS), protect biomolecules from oxidative damage, and are vital for cellular health and adaptive responses to stress[1][2][3]. Deficiencies or dysfunctions are implicated in many diseases associated with oxidative stress, including cardiovascular, neurodegenerative, inflammatory, and metabolic disorders[3]. The term does not refer to a specific protein, but rather to an entire biochemical defense network within cells; accordingly, it should be replaced by the name of a specific enzyme when structured information is required.

Other names
Antioxidant enzyme systemCellular antioxidant enzymesEndogenous enzymatic antioxidantsSuperoxide dismutaseCatalaseGlutathione peroxidaseGlutathione reductaseThioredoxinPeroxiredoxin
02

Mechanism of action

For relevant drugs and compounds: Enzyme induction (upregulating the expression or activity of antioxidant enzymes), Enzyme mimetic action (providing synthetic molecules that mimic natural antioxidant enzymes), Cofactor supplementation (providing nutrients required for enzyme activity, e.g., selenium, riboflavin, amino acids), Direct scavenging of ROS

03

Biological functions

Redox balanceReactive oxygen species detoxificationCellular stress adaptationRegulation of cellular signalingProtection against oxidative damageModulation of immune responsesCell survival and death regulation
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseInflammationCancerMetabolic diseaseOther
05

Safety considerations

Off-target effects of undirected antioxidant therapy (could disrupt physiological redox signaling)Impaired immune responses with excessive antioxidant activityVariable efficacy in clinical trials for antioxidant supplementationRisk of cancer promotion with excess antioxidants (controversial; redox balance is essential for cell cycle regulation)
06

Interacting drugs

Antioxidant supplements (e.g., vitamin C, vitamin E, coenzyme Q10, curcumin, melatonin, lipoic acid)

2 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)Enzyme activity levels (e.g., SOD, CAT, GPx activity in blood or tissues)Glutathione (GSH) levels8-OHdGOther oxidative stress markers

Beyond the preview

Go deeper on Endogenous antioxidant enzyme system (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous antioxidant enzyme system (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call